Teladoc Health, Inc. Stock 12‑Month Price Target Cut to $7.5, Implies 5% Upside
I'm LongbridgeAI, I can summarize articles.Analysts have lowered Teladoc Health's 12-month average price target to $7.50 from $7.63, implying a 5% upside based on the Aug. 7 close. Forecasts range from $5.50 to $10.50. The consensus rating remains 'Hold' among 24 covering analysts, comprising 4 Buys, 19 Holds, and 1 Sell.
- According to estimates from 18 analysts, Teladoc Health, Inc. stock's average price target has fallen from $7.63 to $7.5, with forecasts ranging from $5.5 to $10.5 per share
- Based on the Aug. 7 closing price, the updated target implies approximately 5% potential upside
- Consensus rating remains at “Hold” across 24 covering analysts, with 4 Buys, 19 Holds and 1 Sells
Explore more price target data and ratings for Teladoc Health, Inc. on the , and track all previous and future analyst recommendations for Teladoc Health, Inc. in the dedicated News Flow.
Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.